Coronary artery bypass graft (CABG)
Coronary artery bypass graft (CABG) is one of the methods used in removing plaque or occlusions caused by arterosclerosis or atherosclerosis. It unclogs the coronary arteries and restores natural blood flow within the heart. It is also known as coronary artery bypass surgery. The increasing cases of cardiovascular disorders (CVD) among the geriatric populace have triggered the need of CABG globally.
Almost 75% of sudden cardiac arrest incidences are treated with CABG. It has a higher approval rating than percutaneous coronary intervention (PCI) or coronary stents. The advent of less invasive techniques within CABG such as endoscopic computer (robotics)-assisted CABG (C-CAB), full-sternotomy “off-pump” CABG (OPCAB), and minimally-invasive direct CABG (MIDCAB) are reducing the mortality rates. OPCAB had a 60% approval rate out of all these methods in Japan and China.
Latest Trends
MAQUET Holdings recently launched the HEARTSTRING III Proximal Seal System to perform CABG without relying on occlusion clamps. This makes it easier to perform saphenous vein conduits. It even reduces complications in coronary artery bypass surgery and increases the life of the patient.
Technology is playing a vital role with the advent of Robotic assisted CABG. Cardiac surgeons at the Wisconsin Heart Hospital have completed off-pump surgeries using the da Vinci(R) Surgical System. This has resulted in shorter surgery durations and higher patient outcome levels.
Market Overview
The worldwide coronary bypass graft (CABG) market is estimated to reach USD 128 million by 2025, according to Grand View Research, Inc. It is expected to proliferate at a CAGR close to 6% over the forecast period (2014 - 2025). It is driven by technologically advanced products like Anastomosis Assist Devices (AAD) and the growing geriatric populace susceptible cardiovascular disorders (CVDs).
Saphenous vein graft surgery is expected to dominate the global market throughout the forecast period. Off-pump CABG is anticipated to gain market shares in the forthcoming years on account of new minimally invasive techniques. North America is expected to lead the market over the forecast period due to rising cases of CVDs and key demographics residing in the region. Prominent market players include Medtronic, Terumo Corporation, KARL STORZ GmbH & Co. KG, and Vitalitec.
In-Depth research report on coronary bypass graft market:
No comments:
Post a Comment